CytomX Therapeutics CTMX
NASDAQ CTMX
$2.40 -0.11 (-4.38%)
At close: Oct 21, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Preferred Dividend Payments (2014 - 2015)

Updated

CytomX Therapeutics (CTMX) recorded Preferred Dividend Payments of $558,000 in Q4 2015, down 53.3% from $1.2 million a year earlier and down 81.1% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends

For FY2015, CytomX Therapeutics reported Preferred Dividend Payments of $6.71 million, up 46.8% from FY2014.

  • Across earlier years, Preferred Dividend Payments came in at $4.57 million in FY2014 (+21.7%) and $3.75 million in FY2013.
  • Per Business Quant, the preceding three quarters came in at $2.96 million (Q3 2015), $1.76 million (Q2 2015) and $1.43 million (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 CytomX Therapeutics 526.55 Mn -431.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 558,000.00
Sep 30, 2015 2.96 Mn
Jun 30, 2015 1.76 Mn
Mar 31, 2015 1.43 Mn
Dec 31, 2014 1.20 Mn
Sep 30, 2014 1.17 Mn
API Access

CytomX Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=CTMX&period=max&api_key=YOUR_API_KEY